Article Sidebar

PDF
Date Published: 22/06/2022
Abstract Views: 220
Views PDF: 179
DOI: https://doi.org/10.51298/vmj.v515i1.2701
Issue
Vol. 515 No. 1 (2022)
Section
Các bài báo
How to Cite
Thế Phương, N. ., Công Long, N. ., Trường Khanh, V. ., Trần Tiến, Đào ., Tuấn Dũng, T. ., & Văn Long, Đào . (2022). EFFECT OF ENDOSCOPIC SUBMUCOSAL DISSESION ON TREAMENT HI-GRADE DYSPLASIA AND EARLY GASTRIC CANCER. Vietnam Medical Journal, 515(1). https://doi.org/10.51298/vmj.v515i1.2701

EFFECT OF ENDOSCOPIC SUBMUCOSAL DISSESION ON TREAMENT HI-GRADE DYSPLASIA AND EARLY GASTRIC CANCER

Nguyễn Thế Phương1,, Nguyễn Công Long2, Vũ Trường Khanh3, Đào Trần Tiến3, Trịnh Tuấn Dũng3, Đào Văn Long1
1 Hanoi Medical University
2 Department of Gastroenterology and Hepatology, Bach Mai Hospital
3 Tâm Anh Hospital

Main Article Content

Abstract

Early gastric cancer (EGC), hi-grade dysplasia (HGD) are defined gastric superficial lesions that invade no more deeply than the submucosal layer. Endoscopic submucosal dissection (ESD) is a well-established and minimally invasive treatment for premalignant and early malignant gastrointestinal (GI) lesions. There are lack of study on ESD procedure in Vietnam. A prospective cross-sectional study aimed to evaluation of efftiveness of ESD procedure in treamet EGC and HGD in Vietnam. 77 patients with EGC or  HGD were peformed ESD, showed that the rate of curative treament was 98,7% the average time of ESD procedure was 86.7 mins; factors related to the longer procedure time were location (antrum vs body of the stomach, 76.7 vs 112,4 mins, respectively, p=0.05), the size of the tumor (<30 mm vs  30-50mm, 67.3 vs 115.7 mins, respectively, p<0.05); bleeding during procedure time was common complication, 32,5%); perforationwas had 1 case but no need surgery. ESD is an effective and safe therapy in the management of early gastric neoplasms.

Article Details

Keywords

early gastric cancer, hi-grade dysplasia, endoscopic submucosal dissesion

References

1. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19. doi:10.1007/s10120-016-0622-4.
2. Banks M, Graham D, Jansen M, et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-1575.
3. ESMO Guidelines Committee, Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, Volume 27, Issue suppl_5, September 2016, Pages v38v49, https://doi.org/10.1093/annonc/mdw350
4. Yusefi, A.R., Risk Factors for Gastric Cancer: A Systematic Review. Asian Pac J Cancer Prev., 2018. 19(3): p. 591-603.
5. Bray, F. , Ferlay, J. , Soerjomataram, I. , Siegel, R. L., Torre, L. A. and Jemal, A. (2018), Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68: 394-424. doi:10.3322/caac.21492
6. Chung, II-Kwun et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointestinal Endoscopy, Volume 69, Issue 7, 1228 - 1235
7. Tanabe, S., et al., Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer, 2014. 17(1): p. 130-136.
8. Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol. 2019;25(27):3546–3562. doi:10.3748/wjg.v25.i27.3546
9. Akintoye E, Obaitan I, Muthusamy A, Akanbi O, Olusunmade M, Levine D. Endoscopic submucosal dissection of gastric tumors: A systematic review and meta-analysis. World J Gastrointest Endosc. 2016;8(15):517–532. doi:10.4253/wjge.v8.i15.517